Sign inJoin waitlistJoin the waitlist

Naamit Gerber

Vice Chair, Education, Radiation Oncology · NYU Grossman School of Medicine

Credentials: · · ·

History

Education · NYU Grossman School of Medicine
Present
Department of Radiation Oncology at NYU Grossman School of Medicine
Present
NYU Grossman School of Medicine
Present

Radiation Oncology
Memorial Sloan Kettering Cancer Center
2011–2015
Preliminary or Transitional Year
2010–2011
Icahn School of Medicine at Mount Sinai
2006–2010

Research

Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis
Journal of Clinical Oncology · 2017 · 386 citations
Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline
Practical Radiation Oncology · 2024 · 144 citations
Erlotinib versus radiation therapy for brain metastases in patients with EGFR-mutant lung adenocarcinoma
International journal of radiation oncology · 2014 · First of 10 authors · 78 citations

Carmen Perez
16 papers
Juhi Purswani
14 papers · 12 as a resident
Moses Tam
10 papers · 9 as a resident
Camille Abeloos
8 papers · 8 as a resident
JK
Jerome Karp
8 papers · 5 as a resident
Shengyang Wu
8 papers · 8 as a resident
Freya Schnabel
7 papers
NH
Nelly Huppert
6 papers
Amber Guth
5 papers
BG
Babak Givi
5 papers
Fauzia Shaikh
5 papers · 3 as a resident
Kenneth Hu
5 papers

Clinical trials

Radiation After No Axillary Nodal Sampling
Principal investigator · Recruiting
NYU Langone Health
2026–2034
Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy
Principal investigator · Recruiting
HeroSupport SA
2026–2027
A Phase II Single-arm Study of Total Body Irradiation With Linac Based VMAT and IGRT
Principal investigator · Completed
NYU Langone Health
2020–2025
Study of the Safety and Efficacy of a Caffeine-based Antifibrosis Cream in Patients With Breast Cancer Undergoing Radiation Therapy
Principal investigator · Active not recruiting · Phase 2
NYU Langone Health
2020–2027